Zobrazeno 1 - 5
of 5
pro vyhledávání: '"C. H. Ewel"'
Autor:
Friedrich Schuening, Huss R, Cong Yu, H. J. Deeg, Kristy Seidel, Dae-Sik Hong, Rainer Storb, C. H. Ewel
Publikováno v:
Annals of Hematology. 74:117-122
The tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) interferes with G1/S-phase progression, and the resulting cell cycle arrest is thought to protect hematopoietic stem cells against injury by cycle-active cytotoxic agents. We investigated the radiopr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aaa3443e3a8d9882f28530faf3cd8d5
https://doi.org/10.1007/s002770050268
https://doi.org/10.1007/s002770050268
Publikováno v:
Diabetes. 43:518-522
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a693a192b7c05a98125e34dd4db92f5
https://doi.org/10.2337/diabetes.43.4.518
https://doi.org/10.2337/diabetes.43.4.518
Autor:
P M Guyre, Dan L. Longo, C H Ewel, J W Smith nd, William C. Kopp, C Main, W G Alvord, Ronald G. Steis, W J Urba
Publikováno v:
Journal of Immunotherapy. 13:181-190
Interferon-gamma (IFN-gamma) is a potent monocyte/macrophage activating agent that in animal models exhibits a bell-shaped dose-response curve of immunomodulatory activity and antitumor efficacy. Previous clinical trials of IFN-gamma conducted at the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e3968a14e5c6d08f9324931e75829bf
https://doi.org/10.1097/00002371-199304000-00005
https://doi.org/10.1097/00002371-199304000-00005
Autor:
C H, Ewel, W J, Urba, W C, Kopp, J W, Smith, R G, Steis, J L, Rossio, D L, Longo, M J, Jones, W G, Alvord, C M, Pinsky
Publikováno v:
Cancer research. 52(11)
We have performed a phase IB study of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose (poly-ICLC) in combination with interleukin 2 (IL-2) in 25 patients with a variety of cancers. Patients received weekly or b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aa766bc3e6c734c19a2b4e6baa92f0dd
https://pubmed.ncbi.nlm.nih.gov/1591717
https://pubmed.ncbi.nlm.nih.gov/1591717
Autor:
R G, Steis, J W, Smith, W J, Urba, D J, Venzon, D L, Longo, R, Barney, L M, Evans, L M, Itri, C H, Ewel
Publikováno v:
Blood. 77(4)
Although highly active in hairy cell leukemia (HCL), interferons (IFN) are not curative in this disease; current data indicate that prolonged IFN therapy will be necessary to control disease in the majority of patients. We previously observed acquire
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bae9ec8f998b569869f1d41367d14fab
https://pubmed.ncbi.nlm.nih.gov/1704264
https://pubmed.ncbi.nlm.nih.gov/1704264